Literature DB >> 25504004

Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.

Q-H Zhang1, H-T Dou2, P Xu3, S-C Zhuang2, P-S Liu1.   

Abstract

INTRODUCTION: The presence of subset of cancer stem cells (CSCs) called "Side population" (SP) cells has been identified in several solid tumors, responsible for treatment failure especially chemotherapy, and cancer relapse. The present study was aimed to isolate and characterize cancer stem like cells side population cells from high grade ovarian cancer.
METHODS: The collected cancer samples were analyzed for presence of SP cells by FACS using Hoechst 33342 exclusion technique. Further the FACS sorted SP and non-SP cells were subjected to analysis of stem cell surface protein expression by western blot and immunocytochemistry, drug resistance and sphere formation assay.
RESULTS: By FACS, we have identified 3.7% of cancer stem cell like side population cells in ovarian cancer whose prevalence was reduced to 0.5% upon treatment with verapamil an inhibitor of ABC transporter. Further, these sorted SP cells showed over expression of ABCG2 (ABC transporter), stem cell proteins such as CD144, CD44, EpCAM and antiapoptotic factor Bcl-2. Also the SP cells showed high resistance to chemotherapy drugs, have high survival rate and they are highly potential to form tumor spheres.
CONCLUSION: Our data suggest that ovarian cancer contain small sub-population of side population cells which shares some characteristics of stem cells. The co-expression of ABC transporters and stem cells surface markers in SP cells may associate with resistance to chemotherapeutic agents, apoptosis and also supports a role for these cells in tumor recurrence, metastasis and invasion. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25504004     DOI: 10.1055/s-0034-1375609

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  10 in total

1.  Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.

Authors:  Jing Chen; Hulai Wei; Jie Cheng; Bei Xie; Bei Wang; Juan Yi; Baoying Tian; Zhuan Liu; Feifei Wang; Zhewen Zhang
Journal:  Oncol Lett       Date:  2017-11-06       Impact factor: 2.967

Review 2.  Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.

Authors:  Claudia Gasch; Brendan Ffrench; John J O'Leary; Michael F Gallagher
Journal:  Mol Cancer       Date:  2017-02-23       Impact factor: 27.401

3.  STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer.

Authors:  Luwei Wei; Fuqiang Yin; Wei Zhang; Li Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Anti-Proliferation Effect of Theasaponin E₁ on the ALDH-Positive Ovarian Cancer Stem-Like Cells.

Authors:  Ling-Yan Jia; Hui-Long Xia; Zhi-Da Chen; Casey Compton; Heather Bucur; Devendra A Sawant; Gary O Rankin; Bo Li; You-Ying Tu; Yi Charlie Chen
Journal:  Molecules       Date:  2018-06-17       Impact factor: 4.411

5.  A Novel Resveratrol-Arsenic Trioxide Combination Treatment Synergistically Induces Apoptosis of Adriamycin-Selected Drug-Resistant Leukemia K562 Cells.

Authors:  Jing Chen; Baoying Tian; Cunmin Zhou; Jingjing Sun; Li Lin; Shucheng Jin; Quanrui Liu; Siyu Fu; Lian Liu; Hang Liu; Zhewen Zhang; Caili Li; Hulai Wei
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

6.  Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines.

Authors:  Jinsha Koroth; Snehal Nirgude; Shweta Tiwari; Vidya Gopalakrishnan; Raghunandan Mahadeva; Sujeet Kumar; Subhas S Karki; Bibha Choudhary
Journal:  BMC Complement Altern Med       Date:  2019-10-21       Impact factor: 3.659

7.  Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133+ Ovarian Cancer Stem Cells.

Authors:  Qifang Long; Weipei Zhu; Jundong Zhou; Jinchang Wu; Weixian Lu; Cui Zheng; Dongmei Zhou; Ling Yu; Ru Yang
Journal:  Oncol Res       Date:  2016-10-18       Impact factor: 5.574

8.  A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.

Authors:  Chantel Samardzija; Rodney B Luwor; Mila Volchek; Michael A Quinn; Jock K Findlay; Nuzhat Ahmed
Journal:  Mol Cancer       Date:  2015-08-11       Impact factor: 27.401

9.  Small putative NANOG, SOX2, and SSEA-4-positive stem cells resembling very small embryonic-like stem cells in sections of ovarian tissue in patients with ovarian cancer.

Authors:  Irma Virant-Klun; Natasa Kenda-Suster; Spela Smrkolj
Journal:  J Ovarian Res       Date:  2016-03-03       Impact factor: 4.234

10.  MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.

Authors:  Geyan Wu; Aibin Liu; Jinrong Zhu; Fangyong Lei; Shu Wu; Xin Zhang; Liping Ye; Lixue Cao; Shanyang He
Journal:  Oncotarget       Date:  2015-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.